Cuneo Hospital - Hematology Department

Azienda Ospedaliera S. Croce e Carle

Breast Cancer

Leukemia

Acute Myeloid Leukemia

Myeloid Leukemia

Recurrence

Exemestane

Letrozole

Anastrozole

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori

condition

allSponsorName

Clinical Research Technology

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocrine therapy the optimal timing for their has not been clearly defined yet.

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

Azienda Ospedaliera S. Croce e Carle | Cuneo Hospital - Hematology Department

Site insights

Work at this site?

Active trials

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer (GIM10-CONSENT)

Trial sponsors